Coupet Combi 5 mg/10 mg filmom obložene tablete
| Name | Coupet Combi 5 mg/10 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-277014782 |
| Active Substance | rosuvastatinkalcij ezetimib |
| Composition | svaka filmom obložena tableta sadrži 5 mg rosuvastatina u obliku rosuvastatinkalcija i 10 mg ezetimiba |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka Elpen Pharmaceutical Co. Inc., Keratea, Attiki, Grčka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 29.06.2022 |
| MA Period of Validity | 29.06.2027 |
| Classification Number | UP/I-530-09/20-01/238 |
| Registration Number | 381-12-01/154-22-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C10BA06 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
